G1 Therapeutics Inc (NAS:GTHX) Stock News, Headlines & Updates
G1 Therapeutics Inc Stock News from GuruFocus
- 1
Jul 01, 2024
G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
Marketwired • 8:00am
Jun 24, 2024
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)
Marketwired • 6:00am
Jun 05, 2024
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 7:00am
May 28, 2024
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
Marketwired • 6:00am
May 23, 2024
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
Marketwired • 5:00pm
May 22, 2024
G1 Therapeutics to Participate in TD Cowen's 5th Annual Oncology Innovation Summit
Marketwired • 10:00am
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
Marketwired • 6:00am
May 02, 2024
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances Amid Challenges
GuruFocus Research • 1:09am
Q1 2024 G1 Therapeutics Inc Earnings Call Transcript
GuruFocus Research • 11:14pm
May 01, 2024
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • 5:00pm
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 5:00pm
G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
Marketwired • 6:00am
G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
Marketwired • 6:00am
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
GuruFocus Research • 5:54am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news